Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Clinical Transplants|August 7, 2014
Immunoregulation and allogenicity in cardiac stem cell regenerative therapyDominique Charron, Reem Al-Daccak
Current Opinion in Immunology|January 22, 2004
MHC class II signaling in antigen-presenting cellsReem Al-Daccak, Nuala Mooney, Dominique Charron
Journal of Cardiovascular Translational Research|June 19, 2010
Immunogenicity and allogenicity: a challenge of stem cell therapyDominique Charron, Caroline Suberbielle-Boissel, Reem Al-Daccak
Human Immunology|July 14, 2012
Anti-HLA antibodies in regenerative medicine stem cell therapyDominique Charron, Caroline Suberbielle-Boissel, Ryad Tamouza, et al.
European Journal of Immunology|September 5, 2002
MHC class II isotype-specific signaling complex on human B cellsClaire Lévéille, Jean-Gabriel Castaigne, Dominique Charron, et al.
International Immunology|August 31, 2002
A CD18-dependent protein kinase C beta-mediated alternative cell death pathway of activated monocytesJean-Gabriel Castaigne, Wenyan Guo, Claire Lévéille, et al.
European Journal of Immunology|April 3, 2003
Signaling through HLA-DR induces PKC beta-dependent B cell death outside raftsWenyan Guo, Jean-Gabriel Castaigne, Nuala Mooney, et al.
Melanoma Research|December 4, 2004
Class II transactivator (CIITA) isoform expression and activity in melanomaFabrice Baton, Carine Deruyffelaere, Muriel Chapin, et al.
Molecular Therapy. Nucleic Acids|February 14, 2013
Mass spectrometry reveals changes in MHC I antigen presentation after lentivector expression of a gene regulation systemRoland Vogel, Reem Al-Daccak, Oliver Drews, et al.
Pageof 20